IP is one of the key components in attracting financing. Concentrating early on building a solid foundation of broad rights, and pursuing a well-thought-out IP strategy can significantly boost company value.
BaseLaunch together with the law firms Vossius & Partner and Walder Wyss invites you to this online event about the strategic importance of IP and licensing in the context of fundraising or M&A deals for biotech companies.
– Developing a strong patent strategy
– Understanding license agreements
– Biotech fundraising: a legal point of view
– M&A transactions: the value of IP and licensing
Participation is free, however registration is required before April 19, 2021.